U.S. Markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.35-1.66 (-18.42%)
At close: 4:00PM EST
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
No. of Analysts2233
Avg. Estimate-0.51-0.53-2.56-1.87
Low Estimate-0.56-0.58-3.09-2.07
High Estimate-0.47-0.49-2.24-1.49
Year Ago EPS-2.8-1.48-10-2.56
Revenue EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
No. of Analysts3233
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20193/30/20206/29/20209/29/2020
EPS Est.-2.7-2.9-0.47-0.55
EPS Actual-2.8-1.48-0.58-0.47
Difference-0.11.42-0.110.08
Surprise %-3.70%49.00%-23.40%14.50%
EPS TrendCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
Current Estimate-0.51-0.53-2.56-1.87
7 Days Ago-0.51-0.53-2.56-1.87
30 Days Ago-0.51-0.53-2.56-1.87
60 Days Ago-0.51-0.53-2.56-1.87
90 Days Ago-0.55-0.61-2.81-2.01
EPS RevisionsCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCYCCIndustrySector(s)S&P 500
Current Qtr.81.80%N/AN/AN/A
Next Qtr.64.20%N/AN/AN/A
Current Year74.40%N/AN/AN/A
Next Year27.00%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A